| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Albumin-to-Alkaline Phosphatase Ratio as a Novel Prognostic Factor in Patients Undergoing Nephrectomy for Non-Metastatic Renal Cell Carcinoma: Propensity Score Matching Analysis
|
Won, Il
|
|
|
20 |
3 |
p. e253-e262
|
article
|
| 2 |
Assessing Inter-Fraction Changes in The Size and Position of The Penile Bulb During Daily MR-Guided Radiation Therapy to The Prostate Bed: Do We Need to Adjust How We Plan Radiation in The Post-Radical Prostatectomy Setting to Reduce Risk of Erectile Dysfunction?
|
Roy, Amit
|
|
|
20 |
3 |
p. e227-e232
|
article
|
| 3 |
Association Between Perioperative Chemotherapy and Survival in Men Undergoing Radical Resection for Primary Urethral Urothelial Carcinoma: An Analysis of the National Cancer Database
|
Celtik, Kenan
|
|
|
20 |
3 |
p. 244-251
|
article
|
| 4 |
Association of Obesity and Diabetes With Prostate Cancer Risk Groups in a Multiethnic Population
|
Zhu, Denzel
|
|
|
20 |
3 |
p. 299-299.e10
|
article
|
| 5 |
Automated Bone Scan Index to Optimize Prostate Cancer Working Group Radiographic Progression Criteria for Men With Metastatic Castration-Resistant Prostate Cancer
|
Anand, Aseem
|
|
|
20 |
3 |
p. 270-277
|
article
|
| 6 |
Chronic Use of Proton Pump Inhibitors Is Associated With an Increased Risk of Immune Checkpoint Inhibitor Colitis in Renal Cell Carcinoma
|
Yin, Jianyi
|
|
|
20 |
3 |
p. 260-269
|
article
|
| 7 |
Combining CAPRA-S With Tumor IDC/C Features Improves the Prognostication of Biochemical Recurrence in Prostate Cancer Patients
|
Jeyapala, Renu
|
|
|
20 |
3 |
p. e217-e226
|
article
|
| 8 |
Comprehensive genomic profiling of treatment resistant metastatic castrate sensitive prostate cancer reveals high frequency of potential therapeutic targets
|
Kappel, Coralea
|
|
|
20 |
3 |
p. 278-284
|
article
|
| 9 |
Coordinated Pembrolizumab and High Dose IL-2 (5-in-a-Row Schedule) for Therapy of Metastatic Clear Cell Renal Cancer
|
Chatzkel, Jonathan
|
|
|
20 |
3 |
p. 252-259
|
article
|
| 10 |
Editorial Board
|
|
|
|
20 |
3 |
p. A1
|
article
|
| 11 |
Factors Associated With Palliative Intervention Utilization for Metastatic Renal Cell Carcinoma
|
Patel, Hiren V.
|
|
|
20 |
3 |
p. 296-296.e9
|
article
|
| 12 |
Hereditary Cancer Gene Variants in Hispanic Men With a Personal or Family History of Prostate Cancer
|
Ramamurthy, Chethan
|
|
|
20 |
3 |
p. 237-243
|
article
|
| 13 |
Histologic Growth Patterns in Clear Cell Renal Cell Carcinoma Stratify Patients into Survival Risk Groups
|
Sirohi, Deepika
|
|
|
20 |
3 |
p. e233-e243
|
article
|
| 14 |
Identification of Different miRNAs and Their Relevant miRNA Targeted Genes Involved in Sister Chromatid Cohesion and Segregation (SCCS)/chromatin Remodeling Pathway on T1G3 Urothelial Carcinoma (UC) Response to BCG Immunotherapy
|
Awadalla, Amira
|
|
|
20 |
3 |
p. e181-e189
|
article
|
| 15 |
Impact of 18 FDG- PET CT in the Management of Muscle Invasive Bladder Cancer
|
Bertolaso, Pauline
|
|
|
20 |
3 |
p. 297-297.e6
|
article
|
| 16 |
Impact of Multiparametric MRI and PSA Density on the Initial Indication or the Maintaining in Active Surveillance During Follow-Up in low-Risk Prostate Cancer
|
Saout, Kevin
|
|
|
20 |
3 |
p. e244-e252
|
article
|
| 17 |
Modified 5-Item Frailty Index Score as Prognostic Marker After Radical Cystectomy in Bladder Cancer
|
Yamashita, Shimpei
|
|
|
20 |
3 |
p. e210-e216
|
article
|
| 18 |
Neoadjuvant Chemotherapy in Elderly Patients With Upper Tract Urothelial Cancer: Oncologic Outcomes From a Multicenter Study
|
Grossmann, Nico C.
|
|
|
20 |
3 |
p. 227-236
|
article
|
| 19 |
Nivolumab VERSUS Cabozantinib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma: A Real-World Comparison
|
Santoni, Matteo
|
|
|
20 |
3 |
p. 285-295
|
article
|
| 20 |
Nomograms for Metastasis-Free and Overall Survival for Pathologically Node Positive Prostate Cancer Patients Treated With or Without Radiation Therapy Plus Short-Term ADT
|
Hutten, Ryan
|
|
|
20 |
3 |
p. e263-e269
|
article
|
| 21 |
Parenchymal Mass Loss During Partial Nephrectomy: Role of Devascularized Parenchymal Mass and Excised Parenchymal Mass and Impact on Functional Preservation
|
Liu, Qi
|
|
|
20 |
3 |
p. e199-e204
|
article
|
| 22 |
Patient Perceptions Regarding Routine Oncologic Follow-Up for Urologic Malignancies
|
Strausser, Sarah A.
|
|
|
20 |
3 |
p. 298-298.e11
|
article
|
| 23 |
RNA sequencing in a penile cancer cohort: an investigation of biomarkers of cisplatin resistance and potential therapeutic drug targets
|
Ibilibor, Christine
|
|
|
20 |
3 |
p. 219-226
|
article
|
| 24 |
Single Positive Core Prostate Cancer at Biopsy: Clinicopathological Implications and Risk Factors for Adverse Pathological Outcomes
|
Mao, Qiqi
|
|
|
20 |
3 |
p. e205-e209
|
article
|
| 25 |
Table of contents
|
|
|
|
20 |
3 |
p. A3-A7
|
article
|
| 26 |
The Cancer of the Bladder Risk Assessment (COBRA) score accurately predicts cancer-specific survival after radical cystectomy: external validation and lymphovascular invasion assessment value to improve its performance
|
Colomer Gallardo, Anna
|
|
|
20 |
3 |
p. 199-209
|
article
|
| 27 |
The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical Nephroureterectomy
|
Martini, Alberto
|
|
|
20 |
3 |
p. e190-e198
|
article
|
| 28 |
Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients
|
Thana, Myuran
|
|
|
20 |
3 |
p. 210-218
|
article
|
Journal description